John Gutheil
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
Papers in
- Oncology 16
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 4
-
- Glycosylation and Glycoproteins Research 5
- Co-authors
- Louis Fehrenbacher (3 shared papers)Stanford J. Stewart (3 shared papers)Charles L. Vogel (3 shared papers)Debu Tripathy (3 shared papers)Melody Cobleigh (3 shared papers)Lyndsay N. Harris (3 shared papers)Michael Burchmore (3 shared papers)Dennis J. Slamon (3 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)Blood (3 papers)Molecular Cancer Therapeutics (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)The Journal of Urology (2 papers)
- Partner nations
- United StatesTaiwanNew Zealand
In The Last Decade
John Gutheil
39 papers receiving 4.0k citations
John Gutheil's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 2.3k
- Radiology, Nuclear Medicine and Imaging 1.2k
- Genetics 404
- Pathology and Forensic Medicine 635
- Cancer Research 457
Countries citing papers authored by John Gutheil
This map shows the geographic impact of John Gutheil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Gutheil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Gutheil more than expected).
Fields of papers citing papers by John Gutheil
This network shows the impact of papers produced by John Gutheil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Gutheil. The network helps show where John Gutheil may publish in the future.
Co-authors
The 25 scholars most cited alongside John Gutheil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer Hit paper breakdown → | 2002 | 1508 |
| 2 | Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer Hit paper breakdown → | 2001 | 507 |
| 3 | 1999 | 431 | |
| 4 | 1999 | 281 | |
| 5 | 2017 | 190 | |
| 6 | 2002 | 157 | |
| 7 | 2001 | 145 | |
| 8 | A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia. | 2000 | 123 |
| 9 | 1996 | 120 | |
| 10 | 2003 | 118 | |
| 11 | Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma. | 2001 | 90 |
| 12 | Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody. | 1999 | 88 |
| 13 | 2006 | 83 | |
| 14 | 2006 | 74 | |
| 15 | 2009 | 68 | |
| 16 | 2002 | 61 | |
| 17 | 2011 | 24 | |
| 18 | 2023 | 16 | |
| 19 | 2019 | 12 | |
| 20 | 1990 | 10 |
About John Gutheil
John Gutheil is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cancer Research, having authored 40 papers that have together received 4.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer Research and Treatments (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Glycosylation and Glycoproteins Research (5 papers), Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Oncology (2.3k citations), Radiology, Nuclear Medicine and Imaging (1.2k citations), Genetics (404 citations), Pathology and Forensic Medicine (635 citations) and Cancer Research (457 citations). John Gutheil has collaborated with scholars based in United States, Taiwan and New Zealand. Frequent co-authors include Louis Fehrenbacher, Stanford J. Stewart, Charles L. Vogel, Debu Tripathy, Melody Cobleigh, Lyndsay N. Harris, Michael Burchmore, Dennis J. Slamon, William Novotny and Steven Shak. Their work appears in journals such as Journal of Clinical Oncology, Blood, Molecular Cancer Therapeutics, Cancer Chemotherapy and Pharmacology and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.